Navigation Links
MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy

safety profile. The most frequently observed sedation-related adverse event in this study was transient hypotension (3%). No adverse events led to procedure or study drug discontinuation.

About Aquavan(R) (fospropofol disodium) Injection

Aquavan(R) (fospropofol disodium) Injection, a proprietary water-soluble prodrug of propofol that after intravenous injection is rapidly converted by an enzyme (alkaline phosphatase) in the body into propofol, is a product candidate in development for sedation of patients undergoing short surgical or diagnostic procedures. Aquavan has not been approved for marketing by the U.S. Food and Drug Administration (U.S. FDA) or any other regulatory agencies.

About MGI PHARMA

MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(R) (decitabine) for Injection, and Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of MGI PHARMA's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause MGI PHARMA's results to differ materially from those expressed or implied by such forward-looking statements include, bu
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/6/2009)...all/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), ... of small-molecule therapeutics for the treatment ...HIV), today reported recent accomplishments and fi...ths ended September 30, 2009. ,, (Logo: http... ) ,, "Since our last quarterly update, we have...
(Date:11/6/2009)... Chimerix, Inc., a biopharmaceutic...erapeutics to address life-threatening diseases, p...,s lead antiviral compound, CMX001, to the World H...urity Initiative (GHSI). CMX001 is a broad-spectr...nt of smallpox, as well as other serious viral inf...
(Date:11/6/2009)...l/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX...biopharmaceutical company developing human vaccine...ency Virus) and other infectious agents, today ann...d provided an operational update. ,, Robert McN... commented, "We are pleased with our progress duri...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 1Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 2HIV Testing Day Set for Saturday in U S 50162 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 2
...n-Probe Incorporated,(Nasdaq: GPRO ) has submitte... supplemental regulatory application for the addit...reen donated blood for the hepatitis B,virus (HBV)...e assay to,screen donated blood for HIV-1 and the ...y is seeking approval to use the assay to screen f...
...1 Alfacell Corporation,(Nasdaq: ACEL ) today ann...,the 5th Cancer Drug Research & Development confer...ys impacted by ONCONASE stimulated,intracellular e... malignant,mesothelioma cell lines. Data presented...ll human cancer cells in cell culture and murine m...
Other Medicine Technology:Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 2Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 3
(Date:11/8/2009)..., Critical legislation would strengthen Medicare...RK, Nov. 8 SUMMARY: Y...s passed critical health care reform legislation t...discrimination by insurance companies that prices ...erage. ,, The Affordable Health Care for Amer...
(Date:11/8/2009)...oring pain now can take you out of the game later,...ay News) -- Foot injuries are the talk of the NFL ...Eli Manning and running back Willie Parker. , O...tion and American Academy of Podiatric Sports Medi...et when they play fall sports like football and la...
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., "One victory does not mean the battle is won,"... 7 In a vote of 240-194...inski-Smith Amendment to prohibit abortion mandate.... ,, Americans United for Life Action President... this amendment is a victory for the pro-life Amer...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...uspected SARS case in six months may have the coro... it was waiting for more results to come in.// ... contracted the SARS coronavirus," Xu Ruiheng, dep...g. A 32-year-old television worker is suspe...
... than 5 million service men and women before and a...reducing an alarmingly high rate of suicide seen a...had been particularly higher for black and white m...osocial problems, with an emphasis on removing the...
...elief that infants' brains don't divide into left-...tudy finds the brain's left hemisphere plays the l...s beginning almost immediately after birth. Re...ime fMRI has been used to study infants. It is a n...
...archers say common cold may help fight cancer. Re...neer the common cold virus so that //it kills canc... They did this by modifying one gene, so the virus.... Specialists say, “When the virus infects cells, ...
...hma have long recommended inhaled corticosteroid (... persistent forms of the condition.But reports abo...ple -- including parents of asthmatic children -- ...problems. Now leading scientists hope to put t...
...peutic option for patients with complicated type 1...e has been controversial. // Now, a new study f...pear to have worse survival than patients on the t... had or need a kidney transplant. However, in the ...
Other Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
... frames are designed with the safety and comfort o...RS-520 (also called SF-6) leaded glass, the indust...enses meet standards, as set for optical clarity, ...tion. ,While our eyewear is protecting your eyes...
Radiation Protection Goggles
Ultralight Jarrod Goggles
QualCraft™ Euro Lite
Medicine Products: